|
|||||
|
|
Effects of exenatide twice daily,exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA1c ≥10.0%: Two pooled analyses including 20 randomised controlled trials |
|
| Authors: | Robert S. Busch James Ruggles Jenny Han Elise Hardy |
| Affiliation: | 1. Albany Medical Center Community Division, The Endocrine Group, Albany, NY, USA;2. Medical Affairs, AstraZeneca, PA, USA;3. Pharmapace, San Diego, CA, USA;4. Clinical Research, AstraZeneca, Gaithersburg, MD, USA |
| Abstract: | |
| Keywords: | exenatide once weekly exenatide twice daily GLP‐1 glucagon‐like peptide‐1 receptor agonist insulin pooled analysis type 2 diabetes |